Efficacy of buparavaquone in the treatment of bovine benign theileriosis

Abstract

The aim of the study was to assess the effectiveness of the buparvaquone in cattle with theileriosis. The study revealed, most of the animals suffer from subclinical or chronic form of theileriosis, which is caused by Theileria orientalis conformed by PCR. Bovine benign theileriosis (BBT) is a mild or subclinical form of disease, which is indicated by the clinical signs and severe anemic haemogram. Inj. Buparavaquone @ 2.5 mg/kg body weight by intramuscular route as single dose has effectively reduced the clinical signs and also improved the heamatology, serum biochemistry and also effectively removed the Theileria orientalis organism from the circulatory system of the animals in 21days post treatment and showed 100% recovery.